Bardin Hill Management Partners LP Decreases Stock Position in Enhabit, Inc. (NYSE:EHAB)

Bardin Hill Management Partners LP reduced its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 88.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,966 shares of the company’s stock after selling 131,432 shares during the quarter. Enhabit accounts for 0.1% of Bardin Hill Management Partners LP’s portfolio, making the stock its 24th biggest holding. Bardin Hill Management Partners LP’s holdings in Enhabit were worth $151,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Kent Lake Capital LLC purchased a new stake in Enhabit during the first quarter valued at $5,183,000. Marshall Wace LLP purchased a new stake in shares of Enhabit during the 2nd quarter valued at about $1,941,000. 8 Knots Management LLC purchased a new position in shares of Enhabit in the fourth quarter worth approximately $1,968,000. DekaBank Deutsche Girozentrale grew its position in Enhabit by 52.3% during the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after buying an additional 178,000 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in Enhabit during the second quarter valued at approximately $955,000.

Insiders Place Their Bets

In other news, Director Jeffrey Bolton acquired 5,000 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was purchased at an average price of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the transaction, the director now directly owns 78,877 shares in the company, valued at approximately $631,804.77. The acquisition was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.90% of the company’s stock.

Enhabit Price Performance

Shares of Enhabit stock opened at $7.55 on Wednesday. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.73. Enhabit, Inc. has a 52 week low of $7.12 and a 52 week high of $11.74. The stock’s 50-day simple moving average is $8.56 and its 200-day simple moving average is $9.28. The company has a market capitalization of $378.43 million, a price-to-earnings ratio of -4.55 and a beta of 1.82.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. Enhabit had a negative net margin of 0.84% and a positive return on equity of 1.61%. The business had revenue of $260.60 million during the quarter, compared to analyst estimates of $265.99 million. During the same period last year, the firm posted $0.04 EPS. As a group, analysts expect that Enhabit, Inc. will post 0.26 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Bank of America cut their price objective on shares of Enhabit from $9.00 to $8.00 and set an “underperform” rating for the company in a research report on Thursday, June 27th. One investment analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and an average price target of $9.35.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.